David Crispino Volpe serves as Executive at AdvanSource Biomaterials Corp, where they oversee executive responsibilities. Since joining the company, David Crispino Volpe has executed 12 insider transactions totaling $5.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 3, 2013 involved purchasing 8,000 shares valued at $400.
David Crispino Volpe currently holds 140,153 shares of AdvanSource Biomaterials Corp (ASNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Crispino Volpe has been a net buyer of ASNB stock. They have purchased $5.2K and sold $0 worth of shares.
David Crispino Volpe's most recent insider trade was on Dec 3, 2013, when they purchased 8,000 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| $0.05 |
| Discretionary |
| Dec 3, 2013 | ASNB | $500 | Purchase | 10,000 | $0.05 | Discretionary |
| Aug 29, 2013 | ASNB | $600 | Purchase | 10,000 | $0.06 | Discretionary |
| Dec 6, 2012 | ASNB | $300 | Purchase | 10,000 | $0.03 | Discretionary |
| Nov 30, 2012 | ASNB | $150 | Purchase | 5,000 | $0.03 | Discretionary |
| Nov 29, 2012 | ASNB | $200 | Purchase | 5,000 | $0.04 | Discretionary |
| Nov 19, 2012 | ASNB | $600 | Purchase | 15,000 | $0.04 | Discretionary |
| Nov 19, 2012 | ASNB | $500 | Purchase | 10,000 | $0.05 | Discretionary |
| Sep 18, 2012 | ASNB | $200 | Purchase | 5,000 | $0.04 | Discretionary |
| Sep 18, 2012 | ASNB | $600 | Purchase | 20,000 | $0.03 | Discretionary |
| Sep 17, 2012 | ASNB | $1.0K | Purchase | 50,000 | $0.02 | Discretionary |